| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |